138 related articles for article (PubMed ID: 6555062)
1. Selective in vitro toxicity of purothionin conjugated to the monoclonal antibody 225.28S to a human high-molecular-weight melanoma-associated antigen.
Imai K; Nakanishi T; Noguchi T; Yachi A; Ferrone S
Cancer Immunol Immunother; 1983; 15(3):206-9. PubMed ID: 6555062
[TBL] [Abstract][Full Text] [Related]
2. Suppression of human melanoma growth in nude mice injected with anti high-molecular-weight melanoma-associated antigen monoclonal antibody 225.28S conjugated to purothionin.
Matsui M; Nakanishi T; Noguchi T; Imai K; Yachi A; Ferrone S
Jpn J Cancer Res; 1985 Feb; 76(2):119-23. PubMed ID: 3920101
[TBL] [Abstract][Full Text] [Related]
3. Selective toxicity of neocarzinostatin-monoclonal antibody conjugates to the antigen-bearing human melanoma cell line in vitro.
Lüders G; Köhnlein W; Sorg C; Brüggen J
Cancer Immunol Immunother; 1985; 20(1):85-90. PubMed ID: 2933140
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
[TBL] [Abstract][Full Text] [Related]
5. Isolation of viable melanoma cells from surgically removed lesions using dishes coated with monoclonal antibody to a high molecular weight melanoma associated antigen.
Natali PG; Segatto O; Zupi G; Cavaliere R; Giacomini P; Ferrone S
J Immunol Methods; 1983 Sep; 62(3):337-46. PubMed ID: 6886437
[TBL] [Abstract][Full Text] [Related]
6. Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen.
Ghose T; Ferrone S; Blair AH; Kralovec Y; Temponi M; Singh M; Mammen M
Cancer Immunol Immunother; 1991; 34(2):90-6. PubMed ID: 1760821
[TBL] [Abstract][Full Text] [Related]
7. Saporin 6 conjugated to monoclonal antibody selectively kills human melanoma cells.
Tecce R; Nicotra MR; Fraioli R; Cuomo M; Trizio D; Natali PG
Melanoma Res; 1991; 1(2):115-23. PubMed ID: 1823624
[TBL] [Abstract][Full Text] [Related]
8. Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen.
Hwang KM; Foon KA; Cheung PH; Pearson JW; Oldham RK
Cancer Res; 1984 Oct; 44(10):4578-86. PubMed ID: 6467213
[TBL] [Abstract][Full Text] [Related]
9. Uptake of methotrexate linked to polyclonal and monoclonal antimelanoma antibodies by a human melanoma cell line.
Uadia P; Blair AH; Ghose T; Ferrone S
J Natl Cancer Inst; 1985 Jan; 74(1):29-35. PubMed ID: 3855485
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
Giacomini P; Natali P; Ferrone S
J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
[TBL] [Abstract][Full Text] [Related]
11. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity of mimotopes with a monoclonal antibody against the high molecular weight melanoma-associated antigen (HMW-MAA) does not predict cross-reactive immunogenicity.
Hafner C; Wagner S; Allwardt D; Riemer AB; Scheiner O; Pehamberger H; Breiteneder H
Melanoma Res; 2005 Apr; 15(2):111-7. PubMed ID: 15846144
[TBL] [Abstract][Full Text] [Related]
13. Potential of palladium-109-labeled antimelanoma monoclonal antibody for tumor therapy.
Fawwaz RA; Wang TS; Srivastava SC; Rosen JM; Ferrone S; Hardy MA; Alderson PO
J Nucl Med; 1984 Jul; 25(7):796-9. PubMed ID: 6737078
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera.
Wilson BS; Kay NE; Imai K; Ferrone S
Cancer Immunol Immunother; 1982; 13(1):69-74. PubMed ID: 7159874
[TBL] [Abstract][Full Text] [Related]
15. Syngeneic antiidiotypic antisera to murine antihuman high-molecular-weight melanoma-associated antigen monoclonal antibodies.
Kusama M; Kageshita T; Tsujisaki M; Perosa F; Ferrone S
Cancer Res; 1987 Aug; 47(16):4312-7. PubMed ID: 3607764
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens.
Kantor RR; Ng AK; Giacomini P; Ferrone S
Hybridoma; 1982; 1(4):473-82. PubMed ID: 6208142
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and mechanism of action of a doxorubicin-monoclonal antibody 9.2.27 conjugate directed to a human melanoma proteoglycan.
Yang HM; Reisfeld RA
J Natl Cancer Inst; 1988 Sep; 80(14):1154-9. PubMed ID: 3261803
[TBL] [Abstract][Full Text] [Related]
18. Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
Hafner C; Breiteneder H; Ferrone S; Thallinger C; Wagner S; Schmidt WM; Jasinska J; Kundi M; Wolff K; Zielinski CC; Scheiner O; Wiedermann U; Pehamberger H
Int J Cancer; 2005 Apr; 114(3):426-32. PubMed ID: 15578703
[TBL] [Abstract][Full Text] [Related]
19. High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells.
Riemer AB; Hantusch B; Sponer B; Kraml G; Hafner C; Zielinski CC; Scheiner O; Pehamberger H; Jensen-Jarolim E
Cancer Immunol Immunother; 2005 Jul; 54(7):677-84. PubMed ID: 15565329
[TBL] [Abstract][Full Text] [Related]
20. The influence of monoclonal antibody dose on tumor uptake of radiolabeled antibody.
Wahl RL; Liebert M; Wilson BS
Cancer Drug Deliv; 1986; 3(4):243-9. PubMed ID: 3567845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
